The control of Pseudomonas aeruginosa infection continues to pose a serious problem in many clinical conditions. Despite intense efforts, the exact mechanism of pathogenicity remains unknown.
A previous report from this laboratory (2) indicated that lethality in experimental infection was due to the in vivo elaboration of a lethal factor(s) produced early in the infectious process, preceding increases in the microbial population which appeared to occur as a terminal event. The extracellular slime of P. aeruginosa has received serious attention and possesses the characteristics of a virulence factor and acts as a protective antigen (4, 10, 11, 14, 15) . More recently, highly purified preparations of slime have been shown to produce toxic manifestations, leucopenia, and death of mice (12) . These events were found to be indistinguishable from those observed during lethal infection produced with viable bacilli. Furthermore, purified slime was also shown to markedly inhibit phagocytosis.
The production of extracellular slime is considered to be a species characteristic of P.
aeruginosa (9) , and in vitro production has been reported under various cultural conditions (5, 6, 8, 9) . However, the in vivo production of extracellular slime has not been reported. The purpose of this study was to demonstrate the in vivo production of slime and its appearance in the peripheral circulation of mice in- 15, fected with P. aeruginosa as further support for the possible role of slime in experimental infection. Although its use is well established in the Pseudomonas literature, in this paper the term "slime" specifically refers to the refined polysaccharide-containing component isolated from the extracellular slime layer.
MATERIALS AND METHODS
Microorganisms and extracellular slime polysaccharides. The organisms used for this study, P. aeruginosa strains BI and EI, were originally isolated from human clinical specimens and have been previously described (3).
The extracellular slime polysaccharides used, slime polysaccharide B (SPB) from strain BI and slime polysaccharide A (SPA) from strain EI, were extracted and purified by previously described procedures (1, 12) , to the extent that column chromatography and immunodiffusion indicated homogeneity.
Animal challenge. Male, white Swiss mice, 20 g, were used in groups of five, and supplied water and Purina mouse chow ad libitum. Each experiment was repeated at least three times. All injections were 0.2 ml by the intraperitoneal route. Various concentrations of slime to be injected were suspended in sterile 0.1 M sodium phosphate-buffered saline (PBS; pH 7.5). Organisms were grown on Trypticase soy agar (Difco) slants for 18 h at 37 C, then suspended in PBS to a turbidity of 750 U in a Klett-Summerson photoelectric colorimeter with a no. 54 green filter. Prior to injection, bacterial cells were washed in 10 ml of PBS and sedimented at 3,500 x g, 10 Mice erythrocytes were collected as peripheral blood samples and sedimented at 100 x g for 5 min. The sedimented erythrocytes were then suspended to final concentration of 5% in PBS, 0.05 ml was added to serial dilutions of the appropriate standard antislime serum, and the hemagglutination titer was determined.
HAI. The inhibitory activity of slime, peritoneal aspirates, or plasma was determined by testing these samples as inhibitor in indirect HA inhibition tests (HAI). The sample (0.1 ml) was added to 0.5-ml serial dilutions of the appropriate standard anti-slime serum. After incubation at room temperature for 60 min, 0.05 ml of the sensitized sheep cells was added to each tube and the hemagglutination titer was determined after a 2-h incubation period at room temperature.
The standard rabbit anti-slime sera employed in these tests were produced with purified slimes of strains BI and El, and demonstrated hemagglutination titers of 640. These sera have been shown to produce a single band when reacted with crude cellular extracts in immunodiffusion tests.
Indirect visualization of slime. Five hours after the injection of viable organisms, peritoneal aspirates were obtained and the bacterial cells were sedimented at 3,500 x g for 10 min. The cells were then resuspended to the original volume in PBS and treated with ferritin-labeled rabbit anti-slime serum or ferritin-labeled rabbit normal serum, conjugated as described by Sri Ram et al. (13) . After (Table 3) .
It was then of interest to ascertain whether HA-inhibitory activity was associated with peritoneal aspirates and plasma samples obtained after infection with P. aeruginosa strain El. It can be seen that HA-inhibitory activity was detectable in both peritoneal aspirates and plasma samples (Fig. 1) (0) and plasma (a) after the intraperitoneal injection of heat-killed cells; peritoneal aspirates (A) and plasma (A) after the intraperitoneal injection of phosphate-buffered saline, pH 7.5. HA inhibition, hemagglutination titer in absence of inhibitor divided by hemagglutination titer obtained when peritoneal aspirates or plasma were added to serial dilutions of anti-slime serum prior to the addition of slime-coated erythrocytes. Titers taken as reciprocal of the highest serum dilution resulting in hemagglutination. levels of inhibitory activity in either the peritoneal aspirates or the plasma. The low level of activity detected in peritoneal aspirates obtained 2 h after injection of heat-killed organisms is presumed to reflect the introduction of preformed slime which was undetectable by the h 12, and produced no observable manifestations in the mice. However, plasma samples taken after the introduction of heat-killed bacteria did not exhibit any detectable HA-inhibitory activity during the observation period. The injection of PBS (pH 7.5) did not evoke HA-inhibitory activity in either peritoneal aspirates or plasma samples. Figure 2 depicts the appearance of HA-inhibitory activity in mice peritoneal aspirates obtained at hourly intervals after the intraperitoneal injection of viable cells of P. aeruginosa strain BI. Inhibitory activity was detectable in the aspirates almost immediately after injection and showed a twofold increase within 1 h. In this case, further increases were not detectable after the h 1, and the activity remained at a constant level during the 5-h observation period. The mice usually succumbed by 15 to 18 h after infection. The injection of heat-killed cells did not result in increased inhibitory activity but rather fell to undetectable levels by 4 h after injection. These mice uniformly survived as did those injected with PBS (pH 7.5). Figure 3A presents an electron micrograph showing the dense localization of ferritinlabeled rabbit anti-slime serum along the entire periphery of P. aeruginosa strain BI, extending outward a considerable distance in an irregular manner. In contrast, the negative control cells reacted with ferritin-labeled normal rabbit serum did not exhibit this reaction (Fig. 3B) . The organisms observed were obtained from the mouse peritoneum 5 h after injection.
DISCUSSION
The purified extracellular slime polysaccharides SPA and SPB, extracted from P. aeruginosa strains El and BI, respectively, are known to be antigenically distinct. This distinction is demonstrable by indirect HA and by mice protection tests (12) . Both active and passive immunization of mice against purified slime have been shown to prevent the toxic manifestations leucopenia and death, produced by injection of slime. More importantly, similar immunizations protected against the identical manifestations observed during lethal infection initiated with viable bacilli (12) . In the same experiments, protection was shown to be strain specific.
Through the use of indirect HAI tests and highly specific antibodies produced against purified slime, the results presented in this paper show that slime can be detected in vitro in concentrations as low as 1 ,g/ml. Increased concentrations of slime resulted in proportionately greater HAI activity.
Based on the specific interaction between slime and its antibody, the HAI test was capable of detecting slime in concentrations of 10 gg/ml in the peripheral circulation as well as in peritoneal aspirates after the injection of slime (12.5 ug/g mouse). Furthermore, peripheral erythrocytes obtained from mice injected with slime (12.5 ug/g) were agglutinated when mixed with specific antibody against slime. These results indicate the presence of slime on the surface of mice erythrocytes which could only have occurred by coating in vivo after the rapid dissemination of slime. Perhaps more significant was the fact that, after intraperitoneal infection of mice with viable cells, the increasing inhibitory activity of slime was detected in the peripheral circulation, as well as in peritoneal aspirates prior to eventual death of the mice. Conversely, the injection of heat-killed cells or PBS did not result in increasing levels of HA-inhibitory activity. Although inhibitory activity could be detected in mice injected with heat-killed cells, this activity was ascribed to the injection of small amounts of preformed slime. In all cases, this small amount of slime fell to undetectable levels and all mice survived. These results are taken as an indication of the in vivo production of slime during lethal infection of mice. Through the use of ferritin-labeled antibody to SPB, slime antibodies were demonstrated to completely sur-VOL. 10, 1974 155 The results presented here are consistent with other studies dealing with experimental infection (2, 12) and clinical observations (7, 16, 17) , which suggest that death in P. aeruginosa infection is related to the liberation of toxic products from the site of primary infection and that septicemia occurs as a terminal event.
With this in mind, specimens obtained from certain clinical cases involving P. aeruginosa infection are being screened for specific HAI activity.
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